New stomach cancer treatment trial tests simpler injection method
NCT ID NCT07449780
Summary
This study is for people with advanced stomach or gastroesophageal junction cancer who haven't had prior treatment. It aims to see if giving the immunotherapy drug AK104 as an injection under the skin (subcutaneous) works as well and is as safe as giving it through an IV, when both are combined with standard chemotherapy. The main goal is to compare how the body processes the drug with each method and to measure how well the treatments control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.